A common polymorphism in the<i>ABCB11</i>gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease
Rika Iwata(University Hospital Zurich), Athanasios Vergopoulos(University Hospital Zurich), Pascal Frei(University Hospital Zurich), Ann K. Daly(Newcastle University), Karim Sabrane(University Hospital Zurich), Beat Müllhaupt(University Hospital of Zurich), Bruno Stieger(University Hospital of Zurich), Oliver Goetze(University Hospital Zurich), Felix Stickel(University Hospital of Zurich), Andreas Geier(Swiss Integrative Center for Human Health), Julia Braun(University of Zurich), Chris Day(Coventry University), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Ina V. Martin(University Hospital Zurich), Katharina Baur(University Hospital Zurich), Johannes Schmitt(University Hospital Zurich)
Cited by 46
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k